Medigene AG – LSE:0QGJ.L
Medigene AG stock price today
Medigene AG stock price monthly change
Medigene AG stock price quarterly change
Medigene AG stock price yearly change
Medigene AG key metrics
Market Cap | 7.38M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -0.95 |
Revenue | 37.28M |
EBITDA | -2.29M |
Income | -24.50M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | -6.16% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeMedigene AG stock price history
Medigene AG stock forecast
Medigene AG financial statements
| Jun 2022 | 25.28M | 13.91M | 55.05% |
|---|---|---|---|
| Dec 2022 | 5.96M | -22.24M | -373.12% |
| Jun 2023 | 3.06M | -6.97M | -227.48% |
| Dec 2023 | 2.97M | -9.20M | -310% |
| 2025 | 6.95M | -13.98M | -201.29% |
|---|---|---|---|
| 2026 | 15.9M | -7.50M | -47.18% |
| 2027 | 20M | -5.69M | -28.45% |
| 2028 | 15M | -9.31M | -62.08% |
Analysts Price target
Financials & Ratios estimates
| Sep 2022 | 51678000 | 14.65M | 28.35% |
|---|---|---|---|
| Dec 2022 | 51678000 | 14.65M | 28.35% |
| Jun 2023 | 42177000 | 11.99M | 28.43% |
| Dec 2023 | 31716000 | 10.65M | 33.58% |
| Jun 2022 | 17.30M | -11.22M | -258K |
|---|---|---|---|
| Dec 2022 | -5.32M | -776K | -24K |
| Jun 2023 | -8.03M | 2.55M | -163K |
| Dec 2023 | -7.08M | -171K | -613K |
Medigene AG alternative data
| Aug 2023 | 66 |
|---|---|
| Sep 2023 | 87 |
| Oct 2023 | 87 |
| Nov 2023 | 87 |
| Dec 2023 | 87 |
| Jan 2024 | 87 |
| Feb 2024 | 87 |
| Apr 2024 | 87 |
| May 2024 | 76 |
| Jun 2024 | 76 |
| Jul 2024 | 76 |
Medigene AG other data
| Patent |
|---|
Grant Filling date: 10 Apr 2017 Issue date: 3 Nov 2020 |
Application Filling date: 26 Jul 2019 Issue date: 18 Jun 2020 |
Application ASSEMBLY ACTIVATING PROTEIN (AAP) AND ITS USE FOR THE MANUFACTURE OF PARVOVIRUS PARTICLES ESSENTIALLY CONSISTING OF VP3 Filling date: 17 May 2019 Issue date: 19 Mar 2020 |
Application Filling date: 19 Aug 2019 Issue date: 20 Feb 2020 |
Grant Filling date: 2 Nov 2015 Issue date: 10 Sep 2019 |
| Insider | Compensation |
|---|---|
Dr. Dolores J. Schendel Chief Executive Officer, Chief Scientific Officer & Member of Executive Management Board | $444,000 |
Dr. Kai Pinkernell Chief Medical Officer, Chief Devel. Officer & Member of Executive Management Board | $421,000 |
Mr. Axel Sven Malkomes Chief Financial Officer, Chief Bus. Devel. Officer & Member of Executive Management Board | $415,930 |
Dr. Horst Domdey (1951) Co-Founder & Member of the Supervisory Board | $33,000 |
Dr. Gary Anthony Waanders Ph.D. Vice President of Investor Relations | |
Dr. Ernst-Ludwig Winnacker Co-Founder & Chairman Scientific Advisory Board |
-
What's the price of Medigene AG stock today?
One share of Medigene AG stock can currently be purchased for approximately $2.97.
-
When is Medigene AG's next earnings date?
Unfortunately, Medigene AG's (0QGJ.L) next earnings date is currently unknown.
-
Does Medigene AG pay dividends?
No, Medigene AG does not pay dividends.
-
How much money does Medigene AG make?
Medigene AG has a market capitalization of 7.38M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 80.69% to 6.03M US dollars.
-
What is Medigene AG's stock symbol?
Medigene AG is traded on the LSE under the ticker symbol "0QGJ.L".
-
What is Medigene AG's primary industry?
Company operates in the Healthcare sector and Medical - Pharmaceuticals industry.
-
How do i buy shares of Medigene AG?
Shares of Medigene AG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Medigene AG's key executives?
Medigene AG's management team includes the following people:
- Dr. Dolores J. Schendel Chief Executive Officer, Chief Scientific Officer & Member of Executive Management Board()
- Dr. Kai Pinkernell Chief Medical Officer, Chief Devel. Officer & Member of Executive Management Board()
- Mr. Axel Sven Malkomes Chief Financial Officer, Chief Bus. Devel. Officer & Member of Executive Management Board()
- Dr. Horst Domdey Co-Founder & Member of the Supervisory Board(age: 74, pay: $33,000)
- Dr. Gary Anthony Waanders Ph.D. Vice President of Investor Relations
- Dr. Ernst-Ludwig Winnacker Co-Founder & Chairman Scientific Advisory Board
-
Is Medigene AG founder-led company?
Yes, Medigene AG is a company led by its founders Dr. Horst Domdey and Dr. Ernst-Ludwig Winnacker.
-
How many employees does Medigene AG have?
As Jul 2024, Medigene AG employs 76 workers, which is 13% less then previous quarter.
-
When Medigene AG went public?
Medigene AG is publicly traded company for more then 17 years since IPO on 7 Dec 2007.
-
What is Medigene AG's official website?
The official website for Medigene AG is medigene.com.
-
How can i contact Medigene AG?
Medigene AG can be reached via phone at +49 89 2000330.
Medigene AG company profile:
Medigene AG
medigene.comLSE
87
Medical - Pharmaceuticals
Healthcare
Medigene AG, a biotechnology company, focuses on the development of T cell immunotherapies for the treatment of cancer. The company is developing personalized T cell-based therapies with a focus on T cell receptor-modified T cells in the areas of unmet medical needs, which are in clinical development. It also focuses on dendritic cell vaccines and T cell-specific monoclonal antibodies. In addition, the company focuses on developing and marketing RhuDex for hepatology and gastroenterology indications. Medigene AG has a strategic partnership with 2seventy bio, Inc. for the development of T cell receptors. The company also has research collaboration agreements on novel cancer antigens for immunotherapies with the Université de Montréal; and with Cytovant Sciences Co. Ltd. It has operations in Europe, the United States, Asia, and internationally. The company was founded in 1994 and is headquartered in Munich, Germany.
Munich, 82152
:
ISIN: DE000A1X3W00
:
